Therefore, we sought to investigate the effect of glycomimetic treatment on stroke-induced reactive astrogliosis by assessing the mean integrated density values (IDV) of GFAP+ve staining in tissue collected 35-days post-stroke (Figure 6 and Figure 7). This evidence concerns the gene GFAP and stroke disorder.